|
Test Catalog
|
|
Dominant CMT Evaluation |
#408 |
|
| Typical Presentation: |
Individuals with a clear dominantly inherited neuropathy in the family, symptoms can be from mild to severe with variable NCVs, testing includes genes that result in both autosomal and X-linked dominant inheritance patterns |
|
| Disease(s) tested for: |
Charcot-Marie-Tooth disease (CMT) |
|
| Test Details |
|
| Test Code: |
408 |
|
| Profile includes: |
Connexin32 Evaluation, EGR2 DNA Sequencing Test, LITAF/SIMPLE DNA Sequencing Test, MFN2 DNA Sequencing Test, Myelin Protein Zero (MPZ) DNA Sequencing Test, Neurofilament Light (NFL) DNA Sequencing Test, PMP22 DNA Sequencing Test, PMP22 Duplication/Deletion DNA Test
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
No |
|
| Special Notes: |
Females with connexin32 (GJB1) mutations may present with a phenotype similar to their male counterparts, thus resembling an autosomal dominant inheritance pattern. This panel helps separate autosomal and X-linked dominant inheritance patterns. |
|
| Technical Information |
|
| Utility: |
Detects duplications/deletions in the PMP22 gene, and sequence variations in PMP22, MPZ (P0), EGR2, CX32 (GJB1), NFL, LITAF/SIMPLE, MFN2 genes |
|
| Methodology: |
Multiplex Ligation-dependent Probe Amplification, Southern blot, Polymerase Chain Reaction (PCR) and DNA Sequencing |
|
| Reference Value: |
Please see individual test listings |
|
| CPT Code(s): |
83891(1), 83896(11), 83898(42), 83900(2), 83901(7), 83904(42), 83914(11), 83909(9), 83912(1) |
|
| Patents: |
5,306,616, 5,691,144, 5,780,223, 5,645,993, 6,001,576, & 5,876,927 |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
20 ml |
| Collection Tube: |
Lavender (EDTA) |
|
| Storage Conditions: |
Room temperature, avoid freezing |
|
| Shipping Conditions: |
Room temperature, avoid freezing. Ship same day, must arrive Monday - Friday. |
|
| Test Turnaround: |
21-28 days |
|
